FTC Ruling Against Schering-Plough Seen Curtailing Settlement Terms
In a case likely to have far-reaching implications for settlements of patent litigation in the pharmaceutical industry, the U.S. Federal Trade Commission ruled Thursday that three drug makers colluded to keep...To view the full article, register now.
Already a subscriber? Click here to view full article